Abstract:Background The majority of autoimmune diseases, e.g. rheumatoid arthritis (RA), are characterized by autoantibodies that are produced by B cells. We have identified several novel post-translationally modified epitopes in collagen type II (CII), a major cartilage constituent that are autoreactive. In mouse models, autoantibodies that bind to these epitopes can either induce or protect against inflammatory arthritis. However, very little is known about the frequencies or phenotype the B cells that produce these autoantibodies in humans. Objectives The aim of this project is to study the B cells that produce autoantibodies reactive to CII-epitopes in patients with RA. Methods Clinical data and peripheral blood were collected from patients with RA (n=100). Titres of CII-reactive serum-autoantibodies were determined by Luminex. The different subsets of B cells that expressed a CII-reactive B cell receptor (BCR) were analysed and isolated in patients with positive (n=10) or negative (n=5) titres for autoantibodies recognizing the CII-epitopes cyc48 (CII-F4-R-Cit) and cyc49 (CII-F4-Cit-R) as well as in healthy controls (n=3) using flow cytometry. Results In patients with detectable autoantibodies to cyc48 and cyc49, their titres were 13761±3815 and 5585±1992 (mean ± SEM), respectively. The corresponding titres in the patients negative for these autoantibodies were 122±55 and 234±75. In autoantibody-positive patients, the frequencies of cells expressing a BCR reactive for cyc48 and cyc49 in different subsets were: transitional cells 0.88±0.18% and 1.33±0.33%; naïve cells 0.09±0.0008% and 0.13±0.06 and memory cells 0.31±0.25 and 0.30±0.12%. All frequencies were well above those detected in patients without cyc48/49 titres and in healthy controls. A higher proportion (p=0.03) of the cyc48/49 positive patients were treated with methotrexate compared to cyc48/49 negative patients, no other clinical differences were recorded. CII-reactive single B cells were isolated in order to clone the BCR Conclusions In patients with manifest RA there is a relatively high and detectable frequency of transitional B cells that express a joint-specific BCR, which suggests that the deletion of autoreactive B cells in the bone marrow in RA patients is defective. As there is a decrease in the proportion of naïve CII-specific B cells, a substantial amount of the autoreactive cells are deleted in the periphery. However, peripheral B-cell tolerance is incomplete, as CII-specific B cells are enriched in the pool of memory B cells. Disclosure of Interest None declared

Detection and Significance of Serum Antibodies Against Type Ⅱcollagen in Patients with Rheumatoid Arthritis

Diagnosis and Application of Combine Detection on Pyridine Cross-linked Comprehensive Peptide of Type Ⅰ Collagen,Matrix Metalloproteinase Enzyme-3 Projects,CCP and RF in Patients with Early Rheumatoid Arthritis

[Significance of Citrullinated Collagen Type II and Its Antibodies in Rheumatoid Arthritis].

A Meta-analysis of Diagnostic Value of Anti-Collagen Ⅱ Antibody for Rheumatoid Arthritis

Clinical utility of anti-citrullinated peptide antibodies in patients with rheumatoid arthritis

Value of Serum Collagen Triple Helix Repeat Containing-1(Cthrc1) and 14-3-3η Protein Compared to Anti-Ccp Antibodies and Anti-Mcv Antibodies in the Diagnosis of Rheumatoid Arthritis

The Autoantibody Response to Cyclic Citrullinated Collagen Type II Peptides in Rheumatoid Arthritis.

Type Ii Collagen Antibody Response is Enriched in the Synovial Fluid of Rheumatoid Joints and Directed to the Same Major Epitopes As in Collagen Induced Arthritis in Primates and Mice

[Relationship Between HLA-DR4/1 Subtypes and T Cell Responses to Type II Collagen or Anti-C II 263-272 Antibodies].

The Role of Collagen Antibodies in Mediating Arthritis

SAT0031 Detection and Isolation of Antigen Specific B Cells in Patients with Rheumatoid Arthritis

[Proliferation of Type II Collagen Specific T Cell Response and Antibody Formation in Rheumatoid Arthritis and Their Relations to HLA-DR4].

Significance of detection of the autoantibodies in patients with rheumatoid Arthritis

[T Cell Proliferative Response and Antibody Formation to Citrullinated Collagen Type II in Patients with Rheumatoid Arthritis].

Rheumatoid arthritis sera antibodies to citrullinated collagen type II bind to joint cartilage

The diagnostic significance of anti-cyclic citrullinated peptide 3.1 IgG/IgA antibody in patients with rheumatoid arthritis

Application of Anti-Ccp Antibody Detection in Rheumatoid Arthritis

[Prevalence and Significance of Antibodies to Citrullinated Human Fibrinogen Β67-77 Peptide in Rheumatoid Arthritis].

Diagnostic Significance of Combined Detection of Rheumatoid Factor and Anticyclic Citrullinated Peptide Antibodies in Rheumatoid Arthritis

Cartilage-Specific Autoimmunity in Rheumatoid Arthritis: Characterization of A Triple Helical B Cell Epitope in the Integrin-Binding-Domain of Collagen Type Ii

Significance of antibodies of IgG, IgA and IgM subtypes antibodies against cyclic citrullinated peptide in early rheumatoid arthritis